VN September 2026

Vetnuus | September 2026 15 Without reliable movement records, these investigations become slower, less accurate, and considerably more expensive. Practical Example Imagine that laboratory testing confirms Foot and Mouth Disease in cattle sold through a regional livestock auction. A robust traceability system enables investigators to identify every purchaser, reconstruct animal movements, notify exposed producers, and implement targeted movement restrictions within hours rather than weeks. Without traceability, authorities may have little option but to impose extensive regional movement restrictions affecting hundreds of farms, many of which were never genuinely exposed. Effective traceability therefore protects both animal health and agricultural commerce. Key Change 10. Movement Control: Protecting Disease-Free Areas Closely linked to traceability is the strengthened regulation of animal movements. South Africa’s livestock industries depend upon frequent movement of animals for breeding, marketing, finishing, slaughter, and export. Leading Article 1986 Regulations Draft Regulations Movement controls primarily during outbreaks Continuous movement documentation and traceability Limited movement records Comprehensive documentation throughout the production chain Focus on individual disease events Traceability integrated into routine livestock management >>>16 At least 10X more selective for JAK11* Starts relieving itch within 2-4 hours2** Reassuring safety and efficacy Broadest weight and age range- safe for dogs and puppies as young as 6 months of age & 2 kg Once daily dosing, at or within 30 minutes of feeding, from day 1 *Over the other JAK enzymes in in vitro assays. **In a canine interleukin-31 (cIL-31)-induced pruritus model. References: 1. Kowalski T, Schuette S. The second-generation Janus kinase inhibitor atinvicitinib is a potent and highly selective inhibitor of JAK1. Vet Dermatol. 2026;0:17. https://doi.org/10.1111/vde.70046 2. Kowalski T, Prohaczik A, Locke K, et al. The second generation Janus kinase inhibitor atinvicitinib significantly reduces pruritus 2-4 hours after dosing dogs in a canine interleukin-31 model. Vet Dermatol. 2026;0:17-18. https://doi.org/10.1111/vde.70046 S4 NUMELVI® 4,8 mg tablets, Reg. No. 25/13/01 (Act 101/1965). Each tablet contains Atinvicitinib 4,8 mg S4 NUMELVI® 7,2 mg tablets, Reg. No. 25/13/02 (Act 101/1965). Each tablet contains Atinvicitinib 7,2 mg S4 NUMELVI® 21,6 mg tablets, Reg. No. 25/13/03 (Act 101/1965). Each tablet contains Atinvicitinib 21,6 mg S4 NUMELVI® 31,6 mg tablets, Reg. No. 25/13/04 (Act 101/1965). Each tablet contains Atinvicitinib 31,6 mg Intervet South Africa (Pty) Ltd | Reg. No. 1991/006580/07 20 Spartan Road, Spartan, 1619, RSA | Private Bag X2026, Isando, 1600, RSA | Tel: +27 (0)11 923 9300 E-mail: msdahza@msd.com | E-mail: salesordersmsd@msd.com | www.msd-animal-health.co.za ZA-NUM-260700001 © 2026 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.

RkJQdWJsaXNoZXIy OTc5MDU=